We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05335928
Recruitment Status : Recruiting
First Posted : April 20, 2022
Last Update Posted : March 17, 2023
Bristol-Myers Squibb
Information provided by (Responsible Party):
Tomas G. Neilan, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2026
Estimated Study Completion Date : April 2027